METOCLOPRAMID BIOFARM 1mg/5ml syrup
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Find medicines for human use by name or active substance.
Browse by initial
561–580 of 1,296 medicines
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: metoclopramide
A03FA01 Alimentary tract and metabolism | Propulsives
Indicated for: nausea and vomiting
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: methotrexate
L01BA01 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
Indicated for: cancer; autoimmune inflammatory diseases
Active substance: metirapone
V04CD01 Various | Other diagnostic agents | Tests for pituitary function
Indicated for: endogenous Cushing syndrome
Active substance: metoprolol
Indicated for: hypertension; angina pectoris
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.